Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis

Deep sequencing and SNP array analyses of pediatric T-cell acute lymphoblastic leukemia reveal NOTCH1 mutations in minor subclones and a high incidence of uniparental isodisomies affecting CDKN2A

(2015) Kristina Karrman et al.   Journal of Hematology & Oncology

Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations

(2014) R. La Starza et al.   BLOOD

Targeting the MYC and PI3K Pathways Eliminates Leukemia-Initiating Cells in T-cell Acute Lymphoblastic Leukemia

(2014) S. Schubbert et al.   CANCER RESEARCH

Chromosome abnormalities in T-cell acute lymphoblastic leukemia in Korea

(2014) Joonhong Park et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches

(2014) Fatemeh Salari et al.   MEDICAL ONCOLOGY

Highly aggressive T-cell acute lymphoblastic leukemia with t(8;14)(q24;q11): extensive genetic characterization and achievement of early molecular remission and long-term survival in an adult patient

(2014) M Parolini et al.   Blood Cancer Journal

High-Dose Cyclophosphamide for the Treatment of Refractory T-Cell Acute Lymphoblastic Leukemia in Children

(2013) Rachel Kobos et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

A case of pediatric γ/δ T-cell malignancy with t(8;14)(q24;q11)/MYC–TCRsuccessfully treated with pulse type chemotherapy followed by stem cell transplant

(2012) Andres Morales La Madrid et al.   LEUKEMIA & LYMPHOMA

Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia

(2011) M. Bonnet et al.   BLOOD